Zuuka: Improving health with wearable medicines

Managing chronic diseases often depends not only on the availability of effective medicines but also on specialist training and patients' ability to follow treatment plans over extended periods. Recognising this challenge, Ōtautahi Christchurch-based medtech spinup Zuuka is developing a world-first wearable drug-delivery platform designed to make long-term treatment simpler, more convenient, and more sustainable. 

The technology originated from research led by Distinguished Professor Geoff Chase in the Mechanical Engineering Department at the University of Canterbury (UC). Zuuka was co-founded by UC graduates Dr Jake Campbell and Jamie Cairns.  

Zuuka's first application is focused on diabetes management, where access to treatment and long-term adherence remain significant challenges. The company aims to create a wearable drug-delivery system that is easier to use, more accessible, and better suited to everyday life than many existing technologies.

At the heart of the platform is a proprietary micro-actuator technology, which replaces traditional motor-driven systems. This enables a significantly smaller device that can operate for more than a year without regular charging or battery replacement.

The platform is designed to integrate with glucose-monitoring systems, smartphone applications, and cloud-based clinical platforms, supporting the growing trend towards personalised and remote healthcare. Beyond diabetes, the technology could also be applied to other therapies including for Parkinson's disease and pulmonary arterial hypertension.

Beyond patient benefits, sustainability is a key focus. Zuuka's reusable pump design could reduce medical waste by up to 99 percent compared with some disposable systems currently on the market, creating both environmental and economic benefits. 

Supported by Te Tītoki Mataora Medtech Research Translator, PreSeed Accelerator Fund and UC's Research and Innovation Commercialisation Team, Zuuka has progressed from university research to commercial development through licensing agreements andaccess to facilities. The venture demonstrates how university research can be translated into practical healthcare innovations with global potential.

 Zuuka is advancing prototype development and preparing for regulatory approval. The technology has the potential to improve treatment adherence, enhance patient experiences, and support more sustainable healthcare.

Talk to Professor Geoff Chase about the dynamic systems modelling and control technologies that underpin this innovation. Contact the Commercialisation Team to explore licensing, partnership, and investment opportunities in healthcare innovation.